Skip to content

Clinical trials

Phase 2/3 Cardiovascular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2/3 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20041
20071
20091
20102
20131
20141
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Aging (NIA)2
Amit N. Patel MD MS1
Cardiol Therapeutics Inc.1
Hemosol1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Parke-Davis1
Stanford University1
The Touro College and University System1
Tufts University1
UConn Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases17
Atherosclerosis4
Diabetes Mellitus3
Hypertension2
Insulin Resistance2
Major Depressive Disorder2
Obesity2
Body Temperature Changes1
Brain Diseases1
Brain Infarction1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.